Revolution Medicines, Inc. (RVMD)

Revolution Medicines experienced significant insider trading activity recently, with 102 transactions totaling over $148 million in sales. Executives, including Alan Sandler and Anthony Mancini, executed planned divestments. These moves follow an August earnings report that missed expectations. The stock remains near its yearly highs despite this heavy selling pressure from corporate leadership.
Ticker: RVMD Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Revolution Medicines, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
76.64
Quantity 46,210 -29.7%
Value US$1,378,597
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
22.94
Quantity 51,851 -43.9%
Value US$4,040,031
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
16.42
Quantity 95,676 -24.8%
Value US$980,331
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
202.81
Quantity 1,000 -1.8%
Value US$202,813
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
201.72
Quantity 1,609 -2.8%
Value US$324,574
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
200.82
Quantity 2,200 -3.7%
Value US$441,801
ALAN SANDLER Officer Officer
Transaction date
Proposed sale
Price
201.74
Quantity 6,309
Value US$1,272,778
2.9
Cislini Jeff SVP & General Counsel Officer
Transaction date
Planned sale
Price
207.32
Quantity 765 -1.5%
Value US$158,600
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
200.54
Quantity 3,121 -7.3%
Value US$625,885
ANTHONY MANCINI Officer Officer
Transaction date
Proposed sale
Price
199.86
Quantity 9,363
Value US$1,871,289
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
200.00
Quantity 587 -1.5%
Value US$117,400
ANTHONY MANCINI Officer Officer
Transaction date
Proposed sale
Price
190.74
Quantity 587
Value US$111,964
3.2
ANDERSON ELIZABETH M Non-Executive Director
Transaction date
Planned sale
Price
195.15
Quantity 100 -2.3%
Value US$19,515
3.2
ANDERSON ELIZABETH M Non-Executive Director
Transaction date
Planned sale
Price
194.59
Quantity 1,500 -25.3%
Value US$291,883
3.2
ANDERSON ELIZABETH M Non-Executive Director
Transaction date
Planned sale
Price
193.44
Quantity 2,648 -30.9%
Value US$512,227
3.2
ANDERSON ELIZABETH M Non-Executive Director
Transaction date
Planned sale
Price
192.54
Quantity 4,985 -36.7%
Value US$959,805
3.2
ANDERSON ELIZABETH M Non-Executive Director
Transaction date
Planned sale
Price
191.85
Quantity 910 -6.3%
Value US$174,585
3.2
Elizabeth Anderson Director Non-Executive Director
Transaction date
Proposed sale
Price
192.76
Quantity 15,080
Value US$2,906,821
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
196.94
Quantity 1,764 -4.2%
Value US$347,402
ANTHONY MANCINI Officer Officer
Transaction date
Proposed sale
Price
196.94
Quantity 1,764
Value US$347,402
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
199.30
Quantity 336 -0.6%
Value US$66,966
Sandler Alan B. Chief Development Officer Officer
Transaction date
Planned sale
Price
194.96
Quantity 5 -0.0%
Value US$975
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
199.30
Quantity 1,747 -4.0%
Value US$348,183
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
195.05
Quantity 27 -0.1%
Value US$5,266
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
199.30
Quantity 5,484 -1.9%
Value US$1,092,979
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
195.01
Quantity 85 -0.0%
Value US$16,576
2.4
GOLDSMITH MARK A See Remarks Executive Director
Transaction date
Planned sale
Price
199.30
Quantity 13,775 -5.2%
Value US$2,745,402
2.4
GOLDSMITH MARK A See Remarks Executive Director
Transaction date
Planned sale
Price
195.01
Quantity 213 -0.1%
Value US$41,537
2.9
Cislini Jeff SVP & General Counsel Officer
Transaction date
Planned sale
Price
199.30
Quantity 3,314 -5.9%
Value US$660,491
2.9
Cislini Jeff SVP & General Counsel Officer
Transaction date
Planned sale
Price
195.01
Quantity 52 -0.1%
Value US$10,140
3.0
Horn Margaret A Chief Operating Officer Officer
Transaction date
Planned sale
Price
199.30
Quantity 4,891 -3.2%
Value US$974,792
3.0
Horn Margaret A Chief Operating Officer Officer
Transaction date
Planned sale
Price
195.01
Quantity 76 -0.0%
Value US$14,821
2.9
Anders Jack Chief Financial Officer Officer
Transaction date
Planned sale
Price
199.30
Quantity 3,992 -3.2%
Value US$795,618
2.9
Anders Jack Chief Financial Officer Officer
Transaction date
Planned sale
Price
195.00
Quantity 61 -0.0%
Value US$11,895
Sandler Alan B Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 331
Value US$67,448
Mancini Anthony Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 2,377
Value US$484,361
2.9
Kelsey Stephen Michael Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 5,415
Value US$1,103,415
2.4
Goldsmith Mark A Officer; Director Executive Director
Transaction date
Proposed sale
Price
203.77
Quantity 13,603
Value US$2,771,883
3.0
Horn Margaret A Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 4,830
Value US$984,209
2.9
Cislini Jeff Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 3,272
Value US$666,735
2.9
Anders Jack Officer Officer
Transaction date
Proposed sale
Price
203.77
Quantity 3,939
Value US$802,650
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
205.81
Quantity 3,270 -1.1%
Value US$672,991
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
204.84
Quantity 4,995 -1.7%
Value US$1,023,189
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
203.87
Quantity 17,949 -5.6%
Value US$3,659,309
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
203.06
Quantity 18,869 -5.6%
Value US$3,831,550
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
201.75
Quantity 21,447 -6.0%
Value US$4,326,947
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
200.78
Quantity 13,368 -3.6%
Value US$2,683,986
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
200.11
Quantity 11,833 -3.1%
Value US$2,367,955
2.9
Kelsey Stephen Michael See Remarks Officer
Transaction date
Planned sale
Price
198.55
Quantity 800 -0.2%
Value US$158,840
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
207.17
Quantity 300 -0.7%
Value US$62,152
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
206.10
Quantity 1,179 -2.6%
Value US$242,991
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
205.05
Quantity 2,420 -5.1%
Value US$496,224
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
204.14
Quantity 5,530 -10.4%
Value US$1,128,870
Mancini Anthony See Remarks Officer
Transaction date
Planned sale
Price
203.28
Quantity 6,019 -10.1%
Value US$1,223,569
ANTHONY MANCINI Officer Officer
Transaction date
Proposed sale
Price
207.68
Quantity 15,448
Value US$3,208,241
ANTHONY MANCINI Officer Officer
Transaction date
Proposed sale
Price
207.68
Quantity 15,448
Value US$3,208,241
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
212.27
Quantity 371 -100.0%
Value US$78,752
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
212.27
Quantity 371 -100.0%
Value US$78,752
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
211.36
Quantity 3,844 -91.2%
Value US$812,463
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
210.50
Quantity 4,730 -52.9%
Value US$995,678
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
209.56
Quantity 2,853 -24.2%
Value US$597,875
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
208.55
Quantity 3,587 -23.3%
Value US$748,081
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
207.33
Quantity 999 -6.1%
Value US$207,125
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
207.33
Quantity 999 -6.1%
Value US$207,125
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
206.60
Quantity 706 -4.1%
Value US$145,863
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
206.60
Quantity 706 -4.1%
Value US$145,863
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
206.15
Quantity 625 -3.5%
Value US$128,846
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
205.19
Quantity 2,128 -10.7%
Value US$436,640
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
204.35
Quantity 7,271 -26.8%
Value US$1,485,830
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
203.55
Quantity 26,160 -49.1%
Value US$5,324,824
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
202.48
Quantity 12,919 -19.5%
Value US$2,615,864
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
201.47
Quantity 6,597 -9.1%
Value US$1,329,117
2.6
Kim Lorence H. Non-Executive Director
Transaction date
Planned sale
Price
200.56
Quantity 300 -0.4%
Value US$60,168
2.6
Lorence H Kim Affiliate
Transaction date
Proposed sale
Price
207.88
Quantity 73,090
Value US$15,193,949
2.9
Cislini Jeff General Counsel Officer
Transaction date
Planned sale
Price
212.06
Quantity 3,314 -5.6%
Value US$702,761
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-28 2026-10-26 PlS Planned sale

See Remarks

Officer
46,210 -29.7%
76.64
US$1,378,597
46,210 -29.7% 76.64 US$1,378,597
2026-10-01 2026-09-29 PlS Planned sale

Chief Development Officer

Officer
51,851 -43.9%
22.94
US$4,040,031
51,851 -43.9% 22.94 US$4,040,031
2026-10-01 2026-09-29 PlS Planned sale

Chief Development Officer

Officer
95,676 -24.8%
16.42
US$980,331
95,676 -24.8% 16.42 US$980,331
2026-10-01 2026-09-29 PlS Planned sale

Chief Development Officer

Officer
1,000 -1.8%
202.81
US$202,813
1,000 -1.8% 202.81 US$202,813
2026-10-01 2026-09-29 PlS Planned sale

Chief Development Officer

Officer
1,609 -2.8%
201.72
US$324,574
1,609 -2.8% 201.72 US$324,574
2026-10-01 2026-09-29 PlS Planned sale

Chief Development Officer

Officer
2,200 -3.7%
200.82
US$441,801
2,200 -3.7% 200.82 US$441,801
2026-09-29 2026-09-29 PrS Proposed sale

Officer

Officer
6,309
201.74
US$1,272,778
6,309 201.74 US$1,272,778
2026-09-29 2026-09-25 PlS Planned sale

SVP & General Counsel

Officer
765 -1.5%
207.32
US$158,600
765 -1.5% 207.32 US$158,600
2026-09-28 2026-09-25 PlS Planned sale

See Remarks

Officer
3,121 -7.3%
200.54
US$625,885
3,121 -7.3% 200.54 US$625,885
2026-09-25 2026-09-25 PrS Proposed sale

Officer

Officer
9,363
199.86
US$1,871,289
9,363 199.86 US$1,871,289
2026-09-28 2026-09-24 PlS Planned sale

See Remarks

Officer
587 -1.5%
200.00
US$117,400
587 -1.5% 200.00 US$117,400
2026-09-24 2026-09-24 PrS Proposed sale

Officer

Officer
587
190.74
US$111,964
587 190.74 US$111,964
2026-09-24 2026-09-22 PlS Planned sale Non-Executive Director
100 -2.3%
195.15
US$19,515
100 -2.3% 195.15 US$19,515
2026-09-24 2026-09-22 PlS Planned sale Non-Executive Director
1,500 -25.3%
194.59
US$291,883
1,500 -25.3% 194.59 US$291,883
2026-09-24 2026-09-22 PlS Planned sale Non-Executive Director
2,648 -30.9%
193.44
US$512,227
2,648 -30.9% 193.44 US$512,227
2026-09-24 2026-09-22 PlS Planned sale Non-Executive Director
4,985 -36.7%
192.54
US$959,805
4,985 -36.7% 192.54 US$959,805
2026-09-24 2026-09-22 PlS Planned sale Non-Executive Director
910 -6.3%
191.85
US$174,585
910 -6.3% 191.85 US$174,585
2026-09-22 2026-09-22 PrS Proposed sale

Director

Non-Executive Director
15,080
192.76
US$2,906,821
15,080 192.76 US$2,906,821
2026-09-22 2026-09-18 PlS Planned sale

See Remarks

Officer
1,764 -4.2%
196.94
US$347,402
1,764 -4.2% 196.94 US$347,402
2026-09-18 2026-09-18 PrS Proposed sale

Officer

Officer
1,764
196.94
US$347,402
1,764 196.94 US$347,402
2026-09-18 2026-09-16 PlS Planned sale

Chief Development Officer

Officer
336 -0.6%
199.30
US$66,966
336 -0.6% 199.30 US$66,966
2026-09-18 2026-09-16 PlS Planned sale

Chief Development Officer

Officer
5 -0.0%
194.96
US$975
5 -0.0% 194.96 US$975
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Officer
1,747 -4.0%
199.30
US$348,183
1,747 -4.0% 199.30 US$348,183
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Officer
27 -0.1%
195.05
US$5,266
27 -0.1% 195.05 US$5,266
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Officer
5,484 -1.9%
199.30
US$1,092,979
5,484 -1.9% 199.30 US$1,092,979
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Officer
85 -0.0%
195.01
US$16,576
85 -0.0% 195.01 US$16,576
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Executive Director
13,775 -5.2%
199.30
US$2,745,402
13,775 -5.2% 199.30 US$2,745,402
2026-09-18 2026-09-16 PlS Planned sale

See Remarks

Executive Director
213 -0.1%
195.01
US$41,537
213 -0.1% 195.01 US$41,537
2026-09-18 2026-09-16 PlS Planned sale

SVP & General Counsel

Officer
3,314 -5.9%
199.30
US$660,491
3,314 -5.9% 199.30 US$660,491
2026-09-18 2026-09-16 PlS Planned sale

SVP & General Counsel

Officer
52 -0.1%
195.01
US$10,140
52 -0.1% 195.01 US$10,140
2026-09-18 2026-09-16 PlS Planned sale

Chief Operating Officer

Officer
4,891 -3.2%
199.30
US$974,792
4,891 -3.2% 199.30 US$974,792
2026-09-18 2026-09-16 PlS Planned sale

Chief Operating Officer

Officer
76 -0.0%
195.01
US$14,821
76 -0.0% 195.01 US$14,821
2026-09-18 2026-09-16 PlS Planned sale

Chief Financial Officer

Officer
3,992 -3.2%
199.30
US$795,618
3,992 -3.2% 199.30 US$795,618
2026-09-18 2026-09-16 PlS Planned sale

Chief Financial Officer

Officer
61 -0.0%
195.00
US$11,895
61 -0.0% 195.00 US$11,895
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
331
203.77
US$67,448
331 203.77 US$67,448
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
2,377
203.77
US$484,361
2,377 203.77 US$484,361
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
5,415
203.77
US$1,103,415
5,415 203.77 US$1,103,415
2026-09-15 2026-09-15 PrS Proposed sale

Officer; Director

Executive Director
13,603
203.77
US$2,771,883
13,603 203.77 US$2,771,883
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
4,830
203.77
US$984,209
4,830 203.77 US$984,209
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
3,272
203.77
US$666,735
3,272 203.77 US$666,735
2026-09-15 2026-09-15 PrS Proposed sale

Officer

Officer
3,939
203.77
US$802,650
3,939 203.77 US$802,650
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
3,270 -1.1%
205.81
US$672,991
3,270 -1.1% 205.81 US$672,991
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
4,995 -1.7%
204.84
US$1,023,189
4,995 -1.7% 204.84 US$1,023,189
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
17,949 -5.6%
203.87
US$3,659,309
17,949 -5.6% 203.87 US$3,659,309
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
18,869 -5.6%
203.06
US$3,831,550
18,869 -5.6% 203.06 US$3,831,550
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
21,447 -6.0%
201.75
US$4,326,947
21,447 -6.0% 201.75 US$4,326,947
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
13,368 -3.6%
200.78
US$2,683,986
13,368 -3.6% 200.78 US$2,683,986
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
11,833 -3.1%
200.11
US$2,367,955
11,833 -3.1% 200.11 US$2,367,955
2026-09-15 2026-09-11 PlS Planned sale

See Remarks

Officer
800 -0.2%
198.55
US$158,840
800 -0.2% 198.55 US$158,840
2026-09-14 2026-09-10 PlS Planned sale

See Remarks

Officer
300 -0.7%
207.17
US$62,152
300 -0.7% 207.17 US$62,152
2026-09-14 2026-09-10 PlS Planned sale

See Remarks

Officer
1,179 -2.6%
206.10
US$242,991
1,179 -2.6% 206.10 US$242,991
2026-09-14 2026-09-10 PlS Planned sale

See Remarks

Officer
2,420 -5.1%
205.05
US$496,224
2,420 -5.1% 205.05 US$496,224
2026-09-14 2026-09-10 PlS Planned sale

See Remarks

Officer
5,530 -10.4%
204.14
US$1,128,870
5,530 -10.4% 204.14 US$1,128,870
2026-09-14 2026-09-10 PlS Planned sale

See Remarks

Officer
6,019 -10.1%
203.28
US$1,223,569
6,019 -10.1% 203.28 US$1,223,569
2026-09-10 2026-09-10 PrS Proposed sale

Officer

Officer
15,448
207.68
US$3,208,241
15,448 207.68 US$3,208,241
2026-09-10 2026-09-10 PrS Proposed sale

Officer

Officer
15,448
207.68
US$3,208,241
15,448 207.68 US$3,208,241
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
371 -100.0%
212.27
US$78,752
371 -100.0% 212.27 US$78,752
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
371 -100.0%
212.27
US$78,752
371 -100.0% 212.27 US$78,752
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
3,844 -91.2%
211.36
US$812,463
3,844 -91.2% 211.36 US$812,463
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
4,730 -52.9%
210.50
US$995,678
4,730 -52.9% 210.50 US$995,678
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
2,853 -24.2%
209.56
US$597,875
2,853 -24.2% 209.56 US$597,875
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
3,587 -23.3%
208.55
US$748,081
3,587 -23.3% 208.55 US$748,081
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
999 -6.1%
207.33
US$207,125
999 -6.1% 207.33 US$207,125
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
999 -6.1%
207.33
US$207,125
999 -6.1% 207.33 US$207,125
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
706 -4.1%
206.60
US$145,863
706 -4.1% 206.60 US$145,863
2026-09-10 2026-09-08 PlS Planned sale Non-Executive Director
706 -4.1%
206.60
US$145,863
706 -4.1% 206.60 US$145,863
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
625 -3.5%
206.15
US$128,846
625 -3.5% 206.15 US$128,846
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
2,128 -10.7%
205.19
US$436,640
2,128 -10.7% 205.19 US$436,640
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
7,271 -26.8%
204.35
US$1,485,830
7,271 -26.8% 204.35 US$1,485,830
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
26,160 -49.1%
203.55
US$5,324,824
26,160 -49.1% 203.55 US$5,324,824
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
12,919 -19.5%
202.48
US$2,615,864
12,919 -19.5% 202.48 US$2,615,864
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
6,597 -9.1%
201.47
US$1,329,117
6,597 -9.1% 201.47 US$1,329,117
2026-09-02 2026-08-31 PlS Planned sale Non-Executive Director
300 -0.4%
200.56
US$60,168
300 -0.4% 200.56 US$60,168
2026-08-31 2026-08-31 PrS Proposed sale

Affiliate

73,090
207.88
US$15,193,949
73,090 207.88 US$15,193,949
2026-08-25 2026-08-21 PlS Planned sale

General Counsel

Officer
3,314 -5.6%
212.06
US$702,761
3,314 -5.6% 212.06 US$702,761

See older Revolution Medicines, Inc. insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Revolution Medicines, Inc. history with Plus

Billed monthly · Cancel anytime